Investorideas.com

Get great ideas from our AI, cannabis, cleantech, crypto, esports and mining podcasts - be a guest or sponsor : 800 665 0411


Share on StockTwits

Investor Ideas Potcasts #515, Cannabis News and Stocks on the Move: (CSE: TER) (OTCQX: TRSSF) (NASDAQ: SNDL)

 

Delta, Kelowna, BC - January 11, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/011121-StocksToWatch.mp3

Investor Ideas Potcasts #515, Cannabis News and Stocks on the Move: (CSE: TER) (OTCQX: TRSSF) (NASDAQ: SNDL)

SHARE PODCAST:      

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today's podcast we will be looking at a few public company announcements.

Virtual Investor Conferences® and KCSA Strategic Communications today announced that the presentations from the January 7th Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com.

Log in to view the presentations now at: https://bit.ly/3ooTxyI

All presentations will be available for 24/7 on-demand replay for 90 days. Investors, advisors and analysts may also download shareholder materials from the "virtual trade booth" for the next three weeks.

The following companies participated in the conference:


TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, announced that it has completed the second phase of construction at its cultivation and manufacturing facility located in Boonton, New Jersey (the "Boonton facility"). This phase of construction added approximately 80,000 square feet of indoor cultivation, to the existing on-site greenhouse and post-harvest manufacturing facilities, bringing the Boonton facility's total current footprint to approximately 140,000 square feet. TerrAscend has the ability to further increase the Boonton facility to 240,000 square feet.

TerrAscend recently received approval from the New Jersey Department of Health ("NJ DOH") to commence cultivation activities within the new indoor facility and expects to complete its first indoor harvests in Q1 2021.

"The New Jersey cannabis market represents a substantial growth opportunity for TerrAscend. With the completion of this expansion we have significantly scaled up our cultivation footprint to meet current demand," said Jason Ackerman, Executive Chairman of TerrAscend. "I'd like to thank our team for their efforts in completing this project and look forward to increasing the availability of our quality medical products to patients across the state."

In August 2020, the Company announced that its approximately 40,000 square foot greenhouse co-located at the Boonton facility was approved by the NJ DOH to begin cultivating cannabis. Concurrently, TerrAscend commenced initial planting of the greenhouse with several harvests completed during Q4 2020. In addition to its current wholesale and retail flower sales, TerrAscend intends to launch its comprehensive suite of high-quality, medical products including pre-rolls, extracted distillate and vaporizable oil, as well as Ilera branded tinctures, topicals and medically-blended vapes.

In December 2018, TerrAscend New Jersey was awarded a license to apply for one of six vertically integrated permits. The Company's application received the second highest score of 146 submissions received by the State. After securing additional processing and dispensing approvals, the full permit allows TerrAscend to operate a production facility and up to three Alternative Treatment Centers ("ATCs"), or dispensaries, in the North region of New Jersey. The first Apothecarium-branded ATC opened in Phillipsburg, NJ in Q4 2020, which will be followed by two additional ATCs in the first half of 2021. The Company's Phillipsburg ATC was the state's first in Warren County.

Sundial Growers Inc. (Nasdaq: SNDL) announced that it has launched high-quality cannabis derivative products under the Top Leaf brand in response to rising consumer demands for solventless cannabis extracts. This most recent launch is consistent with Sundial's focus on premium inhalables, following branded retail offerings of flower, pre-roll and vape cartridges.

"We made a strategic decision to produce these premium products based on demand for solventless, flavorful, pure, and potent cannabis concentrates from a growing group of consumers," said Andrew Stordeur, President and Chief Operating Officer of Sundial. "Our control of the entire manufacturing process from cultivation to extraction enables us to deliver premium quality products on a consistent basis. Adding bubble hash and other advanced concentrates to our product portfolio will expand Sundial's share of this rapidly expanding market segment."

Sundial has launched a bubble hash product under its Top Leaf brand and will launch other products such as pressed hash and live rosin with capabilities to expand future product offerings through different Sundial brands in the coming quarters.

Solventless concentrates from Top Leaf brands are available for purchase in B.C. and Alberta, with plans to be available across the country in the coming months. The Top Leaf brand currently offers Pink Kush and Bubba in the bubble hash format.

All Top Leaf concentrate products are produced from high-quality, single-strain, fresh-frozen flower that is produced to preserve its terpene and cannabinoid profile. There are no additives, no fillers and no artificial flavors added to the products.

Sundial plans on providing additional offerings in the first quarter of 2021 including Top Leaf's Oregon Golden Goat bubble hash and Grasslands' Sativa & Indica hash.

OG DNA Genetics, a globally recognized leading cannabis brand, today announced a partnership agreement with Meristematic, Inc. , a leading cannabis micropropagation and tissue culture provider in California.

The Agreement will allow DNA Genetics the ability to provide licensees with clean cultivars and genetically identical starter plants for cultivation with the help of Meristematic's clean cultivar program. Meristematic's Clean Cultivar Program uses proprietary tissue culture processes to rejuvenate mother plants while simultaneously filtering out diseases and pests. All new mother stock is thoroughly analyzed, using sensitive molecular techniques, to verify that disease-causing organisms are no longer detectible. Growers then use the rejuvenated mother stock to improve in-house clone production. This program allows cultivators to enjoy some of the benefits of tissue culture, without building a lab or hiring expensive staff to manage a tissue culture program.

"DNA is proud to partner with Meristematic to build on its position at the forefront of cannabis innovation as the industry matures. The benefits of tissue culture and genetic marker identification for a cannabis genetic company cannot be overstated," said Don Morris, Co-Founder and Chief Cannabis Officer of DNA Genetics. "It allows us to provide clean genetics and general propagation services at a commercial scale to all of our cultivation partners across the globe in addition to providing a better understanding of the biological and endocannabinoid makeup of our cultivars."

Since its inception, the genetics developed by DNA has won more than 200 awards, in all categories, at the most prestigious cannabis events around the world - making DNA the global standard in breeding and growing truly best-in-class strains. These awards include the High Times' Top 10 Strain of the Year, which was inducted into the High Times Seedbank Hall of Fame in 2009, the High Times' 100 Most Influential People in the Industry, and the High Times' Trail Blazers Award, for contributions made towards uniting the fields of entrepreneurship, politics, and medicine.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

Buy a cannabis guest post on Investorideas.com